RaySearch Laboratories AB (publ)

OM:RAY B Stock Report

Market Cap: SEK 10.7b

RaySearch Laboratories Past Earnings Performance

Past criteria checks 6/6

RaySearch Laboratories has been growing earnings at an average annual rate of 55.6%, while the Healthcare Services industry saw earnings growing at 3.6% annually. Revenues have been growing at an average rate of 14.2% per year. RaySearch Laboratories's return on equity is 24.3%, and it has net margins of 17.7%.

Key information

55.60%

Earnings growth rate

55.59%

EPS growth rate

Healthcare Services Industry Growth-11.69%
Revenue growth rate14.23%
Return on equity24.25%
Net Margin17.66%
Next Earnings Update08 Aug 2025

Recent past performance updates

RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

Mar 01
RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

Recent updates

author-image

RayStation And RayCare Upgrades Will Streamline Adaptive Treatment Planning

Integration of AI and new treatment modules is anticipated to boost efficiency, driving demand and potential revenue growth for RaySearch.

RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings

May 13
RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings

RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

May 09
RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

Apr 25
RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

Apr 09
RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

Mar 01
RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

RaySearch Laboratories' (STO:RAY B) Dividend Will Be Increased To SEK3.00

Feb 26
RaySearch Laboratories' (STO:RAY B) Dividend Will Be Increased To SEK3.00

RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares Climb 28% But Its Business Is Yet to Catch Up

Nov 09
RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares Climb 28% But Its Business Is Yet to Catch Up

RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

May 21
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing

May 11
The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing

RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends

Oct 04
RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends

Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?

Jul 10
Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?

Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?

Nov 17
Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?

Revenue & Expenses Breakdown

How RaySearch Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OM:RAY B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 251,267224602267
31 Dec 241,192204576269
30 Sep 241,169175567267
30 Jun 241,129151565260
31 Mar 241,049101560249
31 Dec 231,02282558238
30 Sep 2398764540229
30 Jun 2394553529230
31 Mar 2386622498232
31 Dec 2284424481239
30 Sep 22768-6477243
30 Jun 22693-38455241
31 Mar 22688-35442238
31 Dec 21642-47422233
30 Sep 21613-46390218
30 Jun 21596-50376204
31 Mar 21605-42368194
31 Dec 20652-9398185
30 Sep 2072624421183
30 Jun 2075143454181
31 Mar 2077774472180
31 Dec 1974250446175
30 Sep 1972764438168
30 Jun 1973385405159
31 Mar 1968484384152
31 Dec 1862779354148
30 Sep 18613118313135
30 Jun 18574104297124
31 Mar 18575103278115
31 Dec 17585118268104
30 Sep 17571121252102
30 Jun 17586151247100
31 Mar 1756316023398
31 Dec 1653115122393
30 Sep 1647210921889
30 Jun 164479420392
31 Mar 164056319396
31 Dec 1539870182102
30 Sep 1537378158105
30 Jun 1534476140100
31 Mar 153197912196
31 Dec 142856010995
30 Sep 142682414196
30 Jun 14235-413896

Quality Earnings: RAY B has high quality earnings.

Growing Profit Margin: RAY B's current net profit margins (17.7%) are higher than last year (9.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: RAY B's earnings have grown significantly by 55.6% per year over the past 5 years.

Accelerating Growth: RAY B's earnings growth over the past year (122.1%) exceeds its 5-year average (55.6% per year).

Earnings vs Industry: RAY B earnings growth over the past year (122.1%) exceeded the Healthcare Services industry 7.4%.

Return on Equity

High ROE: RAY B's Return on Equity (24.3%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 01:44
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RaySearch Laboratories AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Hans MählerDNB Markets
Hans MählerHandelsbanken Capital Markets